Spinal Manipulation for Menstrual Symptoms and Sleep in Individuals with Primary Dysmenorrhea

Launched by NARGES PIRI · Nov 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether a combination of spinal manipulation and connective tissue massage can help improve menstrual symptoms, pain, depression, and sleep quality in women who experience primary dysmenorrhea, which is severe menstrual pain. Researchers will look at three different groups of women: one group will receive the actual treatment, another will receive a fake treatment, and the last group will not receive any treatment at all. The study will involve three weekly sessions over two menstrual cycles, and participants will complete questionnaires to assess their pain, menstrual symptoms, depression, and sleep quality at the beginning and end of the study.

To be eligible to participate, women must be at least 18 years old and have a regular menstrual cycle along with the specific type of pain defined by the study. However, women with certain health issues, such as serious psychiatric disorders, chronic pain conditions, or those who are pregnant or have recently given birth, will not be able to take part. This study aims to provide valuable insights that could lead to better treatment options for those suffering from primary dysmenorrhea.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Being 18 years or older,
• • Having primary dysmenorrhea according to the criteria specified in the Primary Dysmenorrhea Consensus Guide (1. Onset of pain 6 to 24 months after menarche, 2. Pain lasting between 8 to 72 hours, and 3. The most intense pain occurring on the 1st and/or 2nd day of menstruation),
• • Having a regular menstrual cycle (28 ± 7 days).
• Exclusion Criteria:
• • Having gastrointestinal, urogenital, autoimmune, or psychiatric disorders (serious psychiatric disorders that would prevent participation in the study),
• • Having other chronic pain syndromes,
• • Having given birth or a positive pregnancy test,
• • Using an intrauterine device (IUD),
• • Having undergone pelvic surgery,
• • Having used chronic medications, including oral contraceptives or antidepressants, within at least 6 months prior to the study,
• • Having irregular menstrual cycles (shorter than 21 days or longer than 35 days, and/or a cycle variation exceeding 4 days),
• • Having a history of pathological conditions indicating secondary dysmenorrhea.